Skip to content

Sunday, June 29, 2025

Latest:

A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
Researchers uncover rare gene variants contributing to systemic sclerosis risk

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Mpro

Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in the lab

August 31, 2021 COVID-19, COVID-19 drugs, DNA-Encoded Chemistry Technology., drug discovery, Mpro, Research, SARS-CoV-2

Baylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951